Early detection of ototoxicity using 1/6th-octave steps

Journal of the American Academy of Audiology

Volumn 14, Issue 8, 2003, Pages 444-450

  Fausti, Stephen A ^a,d   Helt, Wendy J ^a   Phillips, David S ^a   Gordon, Jane S ^a   Bratt, Gene W ^b,e   Sugiura, Karen M ^c   Noffsinger, Douglas ^c  

^a NATIONAL CENTER FOR REHABILITATIVE AUDITORY RESEARCH   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

1 6th octave steps; Early detection; Hearing loss; Individualized sensitive frequency range; Ototoxicity

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; AUDITORY THRESHOLD; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PERCEPTION DEAFNESS; PURE TONE AUDIOMETRY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; AUDIOMETRY, PURE-TONE; AUDITORY THRESHOLD; FEMALE; FOLLOW-UP STUDIES; HEARING LOSS, SENSORINEURAL; HUMANS; MALE; MIDDLE AGED;

EID: 1542437518     PISSN: 10500545     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. American National Standards Institute. (1989). American National Standard Specification for Audiometers (ANSI S3.6-1989). New York: ANSI.
2. American Speech-Language-Hearing Association. (1994). Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy. ASHA 36:11-19.
3. Carhart R, Jerger J. (1959). Preferred method for clinical determination of pure-tone thresholds. J Sp Hear Dis 24:330-345.
4. Fausti SA, Frey RH, Erickson DA, Rappaport BZ, Cleary EJ, Brummett RE. (1979). A system for evaluating auditory function from 8,000-20,000 Hz. J Acoust Soc Am 66:1713-1718.
5. Fausti SA, Frey RH, Henry JA, Knutsen JM, Olson DJ. (1990). Reliability and validity of high-frequency (8-20kHz) thresholds obtained on a computer-based audiometer as compared to a documented laboratory system J Am Acad Audiol 1:162-170.
6. Fausti SA, Henry JA, Helt WJ, Phillips DS, Noffsinger D, Larson D, Fowler CG. (1999). An individualized, sensitive frequency range for early detection of ototoxicity. Ear Hear 20:497-505.
7. Fausti SA, Henry JA, Schaffer HI, Olson DJ, Frey RH, Bagby GC. (1993). High-frequency monitoring for early detection of cisplatin ototoxicity. Arch Otolaryngol Head Neck Surg 119:661-665.
8. Fausti SA, Larson VD, Noffsinger D, Wilson RH, Phillips DS, Fowler CG. (1994). High-frequency audiometric monitoring strategies for early detection of ototoxicity. Ear Hear 15:232-239.
9. Henley CM, Rybak LP. (1995). Ototoxicity in developing mammals. Brain Res Rev 20:68-90.
10. Kennedy IC, Fitzharris BM, Colls BM, Atkinson CH. (1990). Carboplatin is ototoxic. Cancer Chemother Pharmacol 26:232-234.